1. Division of Cell and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
2. Ischemic/Hypoxic Disease Institute, Department of Physiology, Seoul National University College of Medicine, Seoul, Republic of Korea